Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

In re AGA Medical Corporation, No. 12-M125 (Fed. Cir. July 20, 2012)

Denied
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 12-M125
Decided
July 20, 2012
Judge
Per curiam
Document
Nonprecedential Opinion
Length
3 pages

Note: This order is nonprecedential. Auited States Court of Appeals

for the federal Circuit

IN RE AGA MEDICAL CORPORATION,

Petitioner.

Miscellaneous Docket No. 125

On Petition for Writ of Mandamus to the United States District Court for the District of Delaware in case no. 11-CV-0539, Judge Jerome B. Simandle.

ON PETITION

Before LOURIE, SCHALL and Dyk, Circuit Judges.

Figure on page 1 of the opinion

ORDER

AGA Medical Corporation (AGA) seeks a writ of mandamus directing the United States District Court for the District of Delaware to dismiss the underlying declaratory judgment action brought by W.L. Gore & Associates, Inc. (Gore). Gore opposes. AGA replies.

In denying AGA’s motion to dismiss this action, the district court concluded that a substantial controversy existed because “AGA had, prior to commencement of the2 IN RE AGA MEDICAL CORPORATION 2 suit, asserted rights to discovery in anticipation of amending its patent infringement complaint [in a related case between the parties], based on Gore’s planned launch of the GSO product in Europe, which Gore claims it has the right to do without a license.”

Figure on page 2 of the opinion

The remedy of mandamus is available only in extraordinary situations to correct a clear abuse of discretion or usurpation of judicial power. In re Calmar, Inc., 854 F.2d 461, 464 (Fed. Cir. 1998). AGA has not shown in its papers that the Delaware District Court clearly abused its discretion in denying its motion to dismiss. Moreover, AGA has not shown that meaningful review of this ruling will be lost absent immediate appellate review. See Mallard v. U.S. Dist. Court for S. Dist. of Iowa, 490 U.S. 296, 309 (1989) (a petitioner must establish that it has no other means of obtaining the relief desired). “[E]ven though on normal appeal, a court might find reversible error,” In re Cordis Corp., 769 F.2d 733, 787 (Fed. Cir. 1985), this court has made clear that ordinarily, the fact “a petitioner may suffer hardship, inconvenience, or an unusually complex trial does not provide a basis for a court to grant mandamus." In re Roche Molecular Sys., Inc., 516 F.3d 1003, 1004 (Fed. Cir. 2008).

Accordingly, It Is ORDERED THAT: The petition for a writ of mandamus is denied.

For THE Court JUL 28 2012 /s/ Jan Horbal

y Date Jan Horbaly

Clerk

us, couan reasoF

JUL 20 2012 JAN HORBALY

CLERK

Figure on page 3 of the opinion

33 IN RE AGA MEDICAL CORPORATION ce: R. J. Zayed, Esq.

Andrea Lynn Wayda, Esq. Clerk, United States District Court for the District of Delaware

Clerk, United States District Court for the District of Minnesota

s19

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

In re AGA Medical Corporation, No. 12-M125 (Fed. Cir. July 20, 2012).

Record ID
CAFC-12-M125-20120720
Permalink
https://patentcasewatch.com/opinions/CAFC-12-M125-20120720

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.